Achieve Life Sciences (ACHV) Capital Leases (2010 - 2019)
Achieve Life Sciences (ACHV) recorded quarterly Capital Leases of $20000.0 in Q2 2019, down 16.67% on a QoQ basis from $24000.0 in Q1 2019, and up 11.11% year-over-year from $18000.0 in Q2 2018.
Achieve Life Sciences (ACHV) Capital Leases (2010 - 2019) Analysis & Trends
Achieve Life Sciences has disclosed Capital Leases across 10 years of filings, most recently posting $20000.0 for Q2 2019.
- Quarterly Capital Leases rose 11.11% year-over-year to $20000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $20000.0 (up 11.11% YoY) and the FY2018 annual result came in at $12000.0, changed N/A from the prior year.
- Capital Leases slipped to $20000.0 in Q2 2019, from $24000.0 in the prior quarter.
- Over five years, Capital Leases peaked at $130000.0 in Q2 2015 and troughed at $12000.0 in Q4 2018.
- A 5-year average of $58187.5 and a median of $40500.0 in 2016 frame the typical range for Capital Leases.
- Biggest YoY gain for Capital Leases was 650.0% in 2015; the steepest drop was 96.14% in 2015.
- Tracing ACHV's Capital Leases over 5 years: stood at $105000.0 in 2015, then tumbled by 53.33% to $49000.0 in 2016, then slumped by 67.35% to $16000.0 in 2017, then slipped by 25.0% to $12000.0 in 2018, then surged by 66.67% to $20000.0 in 2019.
- Business Quant data shows ACHV's Capital Leases at $20000.0 in Q2 2019, $24000.0 in Q1 2019, and $12000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 20,000.00 |
| Mar 31, 2019 | 24,000.00 |
| Dec 31, 2018 | 12,000.00 |
| Sep 30, 2018 | 15,000.00 |
| Jun 30, 2018 | 18,000.00 |
| Sep 30, 2017 | 16,000.00 |
| Jun 30, 2017 | 22,000.00 |
| Mar 31, 2017 | 32,000.00 |
| Dec 31, 2016 | 49,000.00 |
| Sep 30, 2016 | 67,000.00 |
| Jun 30, 2016 | 84,000.00 |
| Mar 31, 2016 | 92,000.00 |
| Dec 31, 2015 | 105,000.00 |
| Sep 30, 2015 | 117,000.00 |
| Jun 30, 2015 | 130,000.00 |
| Mar 31, 2015 | 128,000.00 |
| Dec 31, 2014 | 14,000.00 |
| Sep 30, 2014 | 2.87 Mn |
| Jun 30, 2014 | 3.10 Mn |
| Mar 31, 2014 | 3.32 Mn |